Novo Nordisk: Employees Must Return to Office Jan. 1
Novo Nordisk has announced a mandatory return-to-office policy for all employees, effective January 1. Learn more about the new workplace rules for the pharma giant.
pharmaceuticals
Read More
1st Biotech IPO Since February: LB Pharma Upsizes Deal
LB Pharma is set to upsize its initial public offering, marking the 1st biotech listing since February and signaling potential renewed investor confidence.
£1b project cancelled: Merck scraps all UK R&D ops
Pharmaceutical giant Merck has cancelled its flagship £1b project and is ceasing all R&D operations in the UK, a major blow to the nation’s science sector.
IL-17 Drug Phase 3 Success for Junshi’s Psoriasis Med
Junshi Biosciences reports a major phase 3 win for its new il-17 drug targeting psoriasis, signaling a significant advancement and a planned push into the China market.
Gout Drug from Atom Shows Phase 3 Win Over Rivals
Atom’s new gout drug shows promising Phase 3 trial results, suggesting it could be a superior treatment option and effectively challenge current market leaders.